Servatus Biopharmaceuticals Ltd director and CEO Wayne Finlayson gives Andrew Scott from Proactive a brief recap on the company which has two platforms,.
The ASX has had a second triumphant day in a row. The S&P/ASX200 gained 24.60 points or 0.36% to 6,803.80 on lower-than-normal volume. Over the last five.